All In Biotech

Drug Trial Radar · NCT04410445

Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence

A Phase 3, Randomized, Open-label Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence (PIVOT-12)

Last checked: Nov 19, 2026Latest source record: Apr 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 765 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

765

Actual

Start

Jul 27, 2020

Primary completion

Sep 22, 2022

Study completion Sep 22, 2022

Sponsor

Lead sponsor
Nektar TherapeuticsIndustry
Sponsor type
Industry
Collaborators
Bristol-Myers Squibb
First posted
Jun 1, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to compare the efficacy of bempegaldesleukin plus nivolumab versus nivolumab in patients with completely resected Stage IIIA/B/C/D, or Stage IV cutaneous melanoma who are at high risk for recurrence.

Conditions

  • Melanoma
  • Melanoma Stage III
  • Melanoma Stage IV
  • Melanoma (Skin)

Interventions

  • BempegaldesleukinBiological

    Specified dose on specified days

  • NivolumabBiological

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Recurrence-free Survival (RFS) by Blinded Independent Central Review (BICR) of Bempegaldesleukin Plus Nivolumab Versus Nivolumab Alone.Time frame: Up to 21 months

Locations

212 sites in 17 countries. Site status is shown where the registry gives one.

  • Honor Health

    Scottsdale, Arizona

  • Banner MD Anderson Cancer Center

    Little Rock, Arkansas

  • Kaiser Foundation Hospital, Inpatient Pharmacy

    Anaheim, California

  • Kaiser Permanente

    Fontana, California

  • St. Joseph Heritage Healthcare

    Fullerton, California

  • Hematology Oncology Medical Group of Orange County, Inc.

    Orange, California

  • University of California Irvine

    Orange, California

  • Emad Ibrahim, MD, Inc

    Redlands, California

  • Kaiser Permanente

    Riverside, California

  • Southern California Permanente Medical Group

    Riverside, California

  • San Francisco Oncology Associates

    San Francisco, California

  • California Cancer Associates for Research and Excellence

    San Marcos, California

  • Kaiser Permanente

    San Marcos, California

  • Angeles Clinic and Research Institute

    Santa Monica, California

  • John Wayne Cancer Institute

    Santa Monica, California

  • Rocky Mountain Cancer Centers (Littleton) - USOR

    Aurora, Colorado

  • University of Colorado - Cancer Center - PPDS

    Aurora, Colorado

  • MedStar Georgetown University Hospital

    Washington D.C., District of Columbia

  • Orlando Health Cancer Institute

    Longwood, Florida

  • Rush University Medical Center

    Chicago, Illinois

  • Goshen Center For Cancer Care

    Goshen, Indiana

  • University of Kentucky

    Lexington, Kentucky

  • Ochsner Clinic Foundation

    New Orleans, Louisiana

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Mayo Clinic - PIN

    Rochester, Minnesota

  • Washington University School of Medicine

    St Louis, Missouri

  • Frontier Cancer Center and Blood Institute

    Billings, Montana

  • Nebraska Cancer Specialists

    Omaha, Nebraska

  • Nebraska Methodist Hospital

    Omaha, Nebraska

  • University of Nebraska Medical Center

    Omaha, Nebraska

  • Hackensack University Medical Center

    Hackensack, New Jersey

  • Atlantic Health System

    Morristown, New Jersey

  • NYU Langone Medical Center

    New York, New York

  • Columbia University Medical Center - PIN

    New York, New York

  • Icahn School of Medicine at Mount Sinai

    New York, New York

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina

  • Duke Cancer Institute

    Durham, North Carolina

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio

  • The Cleveland Clinic Foundation

    Cleveland, Ohio

  • Providence Cancer Institute, Franz Clinic

    Portland, Oregon

Showing 40 of 212 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.